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doi:10.1016/j.jmii.2011.12.028Background/Purpose: To compare the clinical characteristics of patients with Streptococcus
milleri (SM) and Klebsiella spp. associated pyogenic liver abscess (PLA).
Methods: A retrospective study of patients with PLA due to SM and Klebsiella spp. was con-
ducted. Clinical characteristics, laboratory and radiological features, management and
outcomes were analyzed.
Results: From 2000 to 2009 inclusive, 21 and 140 patients had SM and Klebsiella spp. associated
monomicrobial infected PLA, respectively. A higher incidence of active malignancy occurred in
the SM group (14.3% vs. 3.6%, p < 0.03). The common clinical features of the patients were
fever, chill and right upper quadrant pain. A longer duration (6.3 vs. 4.4 day, p Z 0.04) of
symptoms and a higher incidence of hepatomegaly (14.3% vs. 2.9%, p < 0.01) occurred in
the SM group. Common laboratory and imaging abnormalities included: anemia, leukocytosis,
high erythrocyte sedimentation rate and C-reactive protein, hypoalbuminemia, elevated total
bilirubin and alanine aminotransferase, right hepatic lobe involvement, hypoechoic in ultraso-
nograpghy, rim enhancement and septal lobulation in computed tomography. The biliary tract
disorder was the most common cause of the disease in the two groups. Patients with Klebsiella
spp. associated PLA tended to have more complications: bacteremia (61.6% vs. 31.6%,
p < 0.01) septic shock (33.6% vs. 19%, p Z 0.11), disseminated intravascular coagulation
(20.7% vs. 4.8%, p Z 0.04), metastatic infections (10.7% vs. 0%, p Z 0.06), acute renal and
respiratory failure (5% vs. 0%, p Z 0.14). However, both were effectively managed by theof Medicine and Geriatrics, Tuen Mun Hospital, 23 Tsing Chung Koon Road, Tuen Mun, Hong Kong.
m (S.-T. Law).
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12 S.-T. Law, M.K.K. Licombination of antibiotics and image-guided aspiration with/without drainage, and their
mortality rates were comparable to each other. Those patients with metastatic infection might
need a longer duration (6.07 vs. 5.32 week, pZ 0.144) of antibiotic therapy, which was due to
the longer mean duration (3.85 vs. 2.86, p < 0.04) of an intravenous counterpart.
Conclusion: SM associated PLA tends to have a distinct clinical syndrome as compared with
that of Klebsiella spp. with regard to risk factors, clinical manifestations and complications.
However, both can be effectively treated with a combination of antibiotics and image-
guided aspiration with/without drainage.
Copyright ª 2011, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Pyogenic liver abscess (PLA) has been recognized since the
time of Hippocrates. It is the most common type of visceral
abscess. In a report of 540 cases of intraabdominal
abscesses, PLA accounted for 48% of visceral abscesses.1
This condition is a potentially life threatening condition,
with a mortality rate ranging from 10e40%. Traditionally,
bacterial pathogens commonly associated with PLA include
flora of the gastrointestinal tract, such as Escherichia
coli and other members of the Enterobacteriaceae family,
Streptococcus milleri (SM), Enterococcus species and
anaerobes. Multiple studies have revealed that Klebsiella
spp. has been emerging as the most important cause of PLA
in the Asian population, and it also plays an important role
in the Western population, as it accounts for about 25% of
all cases.2 Recently, SM group organisms have received
increasing attention as potential pathogens.3e5 A prospec-
tive study by Moore-Gillon et al found SM to be the
most common organism isolated from PLA, being found in
13/16 (81.3%) patients.5 The name, Streptococcus milleri,
honoring the oral microbiologist W.D. Miller, was first
proposed by Guhof in 1956, to describe a gamma hemolytic
streptococcus found in an oral cavity.3There are three
species in the SM group: S. intermedius, S. constellatus and
S. anginosus. They are components of the normal flora of
the oropharynx, gastrointestinal tract and uro-genital
tract. These species share a common denominator in the
clinical setting with Klebsiella spp. i.e., a marked tendency
to cause abscess formation. In the past, the recognition of
these organisms was hampered because of taxonomic
confusion and thus their clinical significance may have been
underrated. Recently, Whiley and Beighton observed that
there were three DNA homology groups that correspond
to the type strains of S. constellatus, S. intermedius and
S. anginosus.4 Because of uniformity in classifying these
organisms and appropriate microbiological culture, an
increased incidence of SM group associated liver abscesses
has been observed in several reviews.5 However, there is
still a lack of in-depth reports regarding SM group associ-
ated liver abscess. Identifying the distinct clinical features
of the SM group and the Klebsiella spp group enables us to
start appropriate empirical antibiotic therapy. Thus, the
aim of this study is to review the characteristics of patients
with SM and Klebsiella spp. associated PLA in the following
areas: risk factors, clinical features, characteristic features
of liver abscess, treatment and outcome.Methods
The records of patients discharged from Tuen Mun hospital
in Hong Kong with a diagnosis of PLA (International Clas-
sification of diseases code, 572.0) between January 2000
and December 2009 were reviewed. Cases were identified
through searching the hospital database (Clinical Manage-
ment System of Hospital Authority of Hong Kong). Under-
estimation of actual caseload is possible, as coding might
have not included patients suffering the underlying
disease. Case definition required patients to have one or
more filling defects on liver imaging (either ultrasound (US)
or computed tomography (CT) scan) together with positive
blood/pus cultures of SM and Klebsiella spp. Those PLAs
with mixed growth were excluded. The clinical records of
these patients were retrospectively reviewed, to obtain
the demographic characteristics, clinical features, labo-
ratory, imaging findings, treatment methods and final
outcomes.
Looking for underlying etiology
The PLA was considered secondary to biliary tract disease in
patients with a clinical picture of cholecystitis or chol-
angitis or documented biliary ductal abnormality. It was
attributed secondary to portal spread, when there was
documented infection or pathology in the distribution of
portal venous circulation. It was considered secondary
to systemic hematogenous spread when a documented
bacteremic episode with another source of infection was
found before the onset of PLA. Cryptogenic abscess was
defined when there was no obvious source of infection after
appropriate investigations.
Management strategies
In general, a broad-spectrum antibiotic was given after the
initial sepsis work-up. Imaging was performed in every case
of suspected PLA and percutaneous needle aspiration of
liver abscess was selected if the abscess was greater than
3 cm in diameter or there was a feature of on-going sepsis,
despite antibiotic treatment. The procedure was usually
performed using a 22 G Chiba needle under real-time US or
CT guidance in the radiology department. The decision
for continuous catheter drainage was determined by the
attending radiologists and the drainage was done by an 8
PLA caused by Streptococcus milleri and Klebsiella spp. 13French pigtail catheter. Surgical drainage was reserved for
patients who failed to respond to antibiotics and percuta-
neous drainage, or those who had a surgical indication
requiring open surgical management. Lastly, follow-up
imaging was performed to confirm the resolution of the
liver abscess.
Statistical analysis
The data were compiled and analyzed by use of the
commercial Statistical Package for the Social Sciences
(SPSS) for Window (version 17.0, SPSS Inc., Chicago, Illinois,
USA). All continuous variables were expressed as mean 
standard deviation (SD). Categorical variables were re-
ported as percent. The Student t test, Chi-square test,
Fisher’s exact test and Mann-Whitney U test were used
when appropriate. A p value of & .05 was considered
statistically significant.
Results
From January 2000 to December 2009 inclusive, a total of
319 patients were diagnosed with PLA, in which 21 and 140
patients were caused by the SM group and Klebsiella spp.
associated monomicrobial infection, respectively.
The demographic characteristics of these patients are
shown in Table 1. Male dominance was found in patients
with Klebsiella spp. infection. Major comorbidities of
patients in the SM group and Klebsiella spp. group were
similar and they included hypertension, ischemic heart
disease, diabetes mellitus and stroke. Active malignancy
was present in three (14.3%) patients (one patient each
with newly detected cholangiocarcinoma and cancer of the
gallbladder, and one with cholangiocarcinoma on palliative
management) of the SM group and four (3.6%) patients










Duration of symptoms before presentation, mean days (SD)
Symptoms and signs
Fever and chill





Right pleural effusion/consolidation (on admission)
Data are no. (%) unless otherwise indicated. Boldface type indicatesof the pancreas) of the Klebsiella spp. group, with
a statistically significant difference (14.3% vs. 3.6%,
p < 0.03) between the two groups.
The clinical features of PLA caused by the SM group and
Klebsiella spp. are shown in Table 1. The duration of the
symptoms prior to admission of the SM group was longer
than that of Klebsiella spp. (6.3 vs. 4.4 days, pZ 0.04). As
shown in Table 1, the most common presenting features of
patients of both groups were fever and chills, followed by
right upper quadrant pain and diarrhea, with no statistically
significant difference between the two groups, except that
more patients in the SM group experienced abdominal pain
(66.7% vs. 47.1%, p < 0.05). Jaundice was not a common
feature in the two groups. Hepatomegly was more
commonly seen in the SM group (14.3% vs. 3.9%, p < 0.01).
The laboratory findings are summarized in Table 2.
Anemia, leukocytosis, high erythrocyte sedimentation rate
(ESR) and C-reactive protein (CRP), hypoalbuminemia,
elevated total bilirubin and alanine aminotransferase were
the common features, while the patients with Klebsiella
spp. associated PLA had a higher serum level of total bili-
rubin (34.6 vs. 18.6 mmol/L, p < 0.05) and alanine amino-
transferase (106 vs. 57 U/L, p < 0.02). More patients with
Klebsiella spp. associated PLA were bacteremic on admis-
sion (61.6% vs. 31.6%, p < 0.01).
US and CT of the abdomen were performed in 6 (28.6%)
and 1 (4.8%) patients in the SM group, and 40 (28.6%) and 12
(8.6%) patients in the Klebsiella spp. group, respectively.
Combined imaging was performed for 14 (66.7%) patients
and 88 (62.9%) patients with SM and Klebsiella spp.,
respectively. The characteristics of PLA found in radiolog-
ical imaging are shown in Table 2. More than 2/3 patients
had a liver abscess at the right hepatic lobe and about 1/10
patients had bilobar involvement, with no statistically
difference between the two groups. The mean size of the
SM associated PLA was 0.9 cm larger than that of the
Klebsiella spp. group, with no statistical difference. Moreith SM and Klebsiella spp. group associated PLA
SM (n Z 21) Klebsiella spp. (n Z 140) p
59 (11.3) 64.8 (13.8) 0.164
10:11 79:61 e
4 (19%) 48 (34.3%) 0.08
4 (19%) 32 (22.9%) 0.34
1 (4.8%) 8 (5.7%) 0.44
1 (4.8) 7 (5%) 0.49
3 (14.3%) 4 (3.6%) <0.03
6.3 (4.1) 4.4 (3.8) 0.04
17 (85.7%) 132 (95%) 0.07
14 (66.7%) 66 (47.1%) <0.05
2 (9.5%) 8 (5.7%) 0.25
3 (14.3%) 35 (25%) 0.14
1 (4.8%) 9 (6.4%) 0.39
3 (14.3%) 4 (2.9%) <0.01
4 (19%) 18 (12.9%) 0.22
statistical significance.
Table 2 Laboratory findings and radiological features of patients with SM and Klebsiella spp. group associated PLA
Laboratory parameters SM (n Z 21) Klebsiella spp. (n Z 140) p
Hemoglobulin (g/dL) 10.9 (1.9) 11.4 (1.8) 0.33
White cell count (109/L) 19.1 (5.1) 16.4 (3.3) 0.16
Erythrocyte sedimentation rate (mm/hr) 82.6 (11.1) 77.6 (17.7) 0.60
C-reactive protein (mg/L) 81.8 (27.2) 165 (36.2) 0.06
Albumin (g/L) 29.1 (6.3) 29.4 (4.9) 0.81
Total bilirubin (mmol/L) 18.6 (5.5) 34.6 (8.7) <0.05
Alanine aminotransferase (U/L) 57 (22.0) 106 (46.2) <0.02
Bacteremia$ 6 (31.6%) 85 (61.6%) <0.01
Radiological features
Size [cm, mean (SD)] 7.4 (2.9) 6.5 (2.8) 0.19
Site
Right lobe 15 (71.4%) 97 (69.3%) 0.42
Left lobe 4 (19.1%) 31 (22.1%) 0.38
Bilobar 2 (9.5%) 12 (8.6%) 0.44
Echogenicity
Hypoechoic 15 (71.4%) 95 (67.9%) 0.37
Hyperechoic/heterogenous 2 (9.5%) 12 (8.6%) 0.44
Thickened wall$$ 7 (33.3%) 24 (17.1%) 0.04
Rim enhancement 12 (57.1%) 68 (48.6%) 0.23
Septal lobulation 13 (61.9%) 84 (60%) 0.43
Aerobila 0 (0%) 9 (6.4%) 0.12
Fluid/gaseous cavitation 19/2 (91%/9.5%) 124/13 (89%/9.3%) 0.39/0.49
Portal thrombophlebitis 1 (4.8%) 2 (1.4%) 0.13
Subcapsular rupture of the abscess 0 (0%) 6 (4.3%) 0.16
$ Blood culture examination was not taken in two patients from each group on admission.
$$ Defined as wall thickness > centimeter.25
Data are mean (standard deviation) or no. (%) of patients, unless otherwise indicated. Boldface type indicates statistical significance.
14 S.-T. Law, M.K.K. Lithan 2/3 of the PLAs within the two groups appeared as
hypoechoic nodules in US imaging; their common CT
imaging features were rim enhancement, lobulated outline
and central fluid/gas formation, with no statistically
significant differences between the two groups. More
abscesses in the SM group had a thickened wall, as
compared with those in the other group (33.3% vs. 17.1%,
p Z 0.04), and no abscess rupture was found in the SM
group (0% vs. 4.3%, p Z 0.16).Table 3 The pathogenesis and confirmatory investigations of p
Pathogenesis SM (
Biliary tract disorder 8 (38




Endoscopic retrograde cholangiopancreatography 1a
Endoscopic ultrasound 2a
Magnetic resonance cholangiopancreatography 2a
Colonoscopy 0
a All cases had normal findings.
b Common bile duct calculi(n Z 8),benign ductal stricture (n Z 6
(n Z 5), gallbladder stones (n Z 6), failed (n Z 2), normal (n Z 38)
c One case had common bile duct stone while the others were norm
d Colonic diverticulitis (n Z 1), normal (n Z 6).The etiologies of the two groups are summarized in
Table 3. Although > one-third of the cases had not been
investigated for the underlying pathology, the biliary tract
disorder was the most common cause of the disease in the
two groups. One patient of the SM group had endoscopic
retrograde cholangiopancreatography (ERCP) performed,
and there was no abnormality detected, while 67 (47.9%)
patients in the Klebsiella spp. group had ERCP and the
findings included: 38 (56.7%) normal findings, eight (11.9%)atients with SM and Klebsiella spp. group associated PLA
n Z 21) Klebsiella spp. (n Z 140) p
.1%) 81 (57.9%) 0.05
) 4 (2.9%) 0.20
) 3 (2.1%) 0.24
5%) 9 (6.4%) 0.30





), malignant ductal stricture (n Z 2), dilated common bile duct
.
al.
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duct stricture, two (3.0%) malignant bile duct stricture, five
(7.5%) dilated common bile duct, six (9.0%) gallbladder
stones, two (3.0%) failed procedure. Endoscopic ultrasound
(EUS) and magnetic resonance cholangiopancreatography
(MRCP) were introduced into our department in 2008 and
2007. From 2008, EUS was performed in two and six patients
(aged 42e71 years, median age Z 55 years) from the SM
and Klebsiella spp. groups, respectively; common bile duct
stone was found in one patient of the Klebsiella spp. group
while the others had normal findings. MRCP was performed
in two and seven patients of the SM and Klebsiella spp.
groups, respectively; a common bile duct stone was seen in
one patient of the Klebsiella spp. group, while the others
had normal findings. Colonoscopy was performed in seven
patients of the Klebsiella spp. group since 2007 and only
one patient had features of colonic diverticulitis while the
others had normal findings.
The management and outcomes of the two groups are
summarized in Table 4. All patients received intravenous
broad-spectrum antibiotics after assessment for sepsis.
Extended-spectrum penicillin (36.6%), third (32.9%) and
second (21.1%) generation cephalosporins were the
commonly used intravenous antibiotics, in which the third-
generation cephalosporin was used more in the Klebsiella
spp. as compared with that in the SM group (35.7% vs.
14.3%, p < 0.03) and the latter group tended to use
extended-spectrum penicillin more (52.4% vs. 34.3%,
p Z 0.054). The commonly used oral antibiotics were:
extended-spectrum penicillin, quinolones and oral secondTable 4 The management and outcomes of the patients with S
Managem
Antibiotic SM (
Time to appropriate antibiotic [day, mean (SD)] 0 (0)
Intravenous, week, mean (SD) 2.2 (
Extended-spectrum penicillin 11 (5
Second generation cephalosporin 4 (19
Third generation cephalosporin 3 (14
Oral, week, mean (SD) 3.2 (
Extended-spectrum penicillin 16 (7
Second generation cephalosporin 3 (14
Quinolone 0 (0%
Intervention
Time interval to have intervention [day, mean(SD)] 3.6 (
Imaging-guided aspiration  drainage 18/1
Surgical drainage 1 (4.
Complications and Outcomes
Metastatic infection 0 (0%
Septic shock 4 (19
DIC# 1 (4.
Acute coronary syndrome 0 (0%
Respiratory/renal failure 0 (0%
ICU care$ 2 (9.
Death 3 (14
# For disseminated intravascular coagulation.
$ For intensive care unit.
Data are no. (%) of patients, unless otherwise indicated. Boldface typgeneration cephalosporins, in which more than 2/3 of
patients with the SM group associated PLA were treated
with penicillin (76.2% vs. 36.4%, p < 0.01) and about 1/5 of
patients in the Klebsiella spp. group had taken oral qui-
nolones (22.9% vs. 0%, p < 0.01). Although there was no
statistically significant difference in the mean duration of
antibiotic treatment between the two groups (5.3 vs. 5.4
week, p Z 0.47), the SM group tended to have a shorter
duration (2.2 vs. 3.1 weeks, p < 0.03) of intravenous
portion and a longer duration (3.2 vs. 2.3 weeks, pZ 0.04)
of oral portion of the antibiotic as compared with those
of Klebsiella spp group. Isolates from PLAs of the SM
group had no antibiotic resistant strains, whereas eleven
(7.9%) isolates from the Klebsiella spp. group had resistant
strains (0 vs. 7.9%, p Z 0.09). There were no isolates with
extended spectrum b-lactamase (ESBL) in our study. The
time to appropriate antibiotic was instant in the SM group;
there was a 0.39  0.02 (mean SD) day delay in having an
appropriate antibiotic prescription in the Klebsiella spp.
group, without any statistically significant difference. The
antibiotic therapy was the only treatment for two (9.5%)
and seven (5%) patients of the SM and Klebsiella spp.
groups, respectively, and the reason for not performing
image-guided aspiration and drainage was the small size of
the lesion (<3 cm in diameter). The mean time intervals to
having imaging-guided intervention were 3.6 and 2.8 days
in the SM and Klebsiella spp. groups, respectively, without
statistical significant difference. Among the SM group,
US-guided needle aspiration was performed in 18 (86%)
patients and continuous catheter drainage was performedM and Klebsiella spp. group associated PLA
ent
n Z 21) Klebsiella spp. (n Z 140) p
0.39 (0.02) 0.46
1) 3.1 (1.7) <0.03
2.4%) 48 (34.3%) 0.054
%) 30 (21.4%) 0.4
.3%) 50 (35.7%) <0.03
2) 2.3 (1.6) 0.04
6.2%) 51 (36.4%) <0.01
.3%) 27 (19.3%) 0.29
) 32 (22.9%) <0.01
1.4) 2.8 (1.1) 0.48
5 (86%/71%) 125/109 (89%/78%) 0.34/0.4
8%) 8 (5.7%) 0.43
) 15 (10.7%) 0.06
%) 47 (33.6%) 0.11
8%) 29 (20.7%) 0.04
) 8 (5.7%) 0.13
) 7 (5%) 0.14
5%) 16 (11.4%) 0.40
.3%) 12 (8.6%) 0.20
e indicates statistical significance.
16 S.-T. Law, M.K.K. Liin 15 (71.4%) patients; in the Klebsiella spp. group, 125
(89.3%) patients had US-guided needle aspiration and
among these, 109 (77.9%) patients had continuous catheter
drainage. A pigtail catheter was not inserted in these 19
patients after percutaneous aspiration, because the
abscess was too solid or it was completely collapsed after
aspiration and thus, further catheter drainage was consid-
ered not useful. Surgical drainage was required in 1(4.8%)
and 8 (5.7%) patients in the SM and Klebsiella spp. groups,
respectively; the main indication of laparotomy among
these patients was the presentation of acute abdomen. No
patients failed to respond to antibiotics, with/without
percutaneous drainage.
Patients in the Klebsiella spp. group tended to have
more adverse events than did patients in the SM group, as
there were more instances of bacteremia (61.6% vs. 31.6%,
p < 0.01), septic shock (33.6% vs. 19%, p Z 0.09), dissem-
inated intravascular coagulation (DIC, 20.7% vs. 4.8%,
p Z 0.04), acute renal and respiratory failure (5% vs. 0%,
p Z 0.14) in patients of Klebsiella spp. group. The distant
spread of the infection was detected in 15(10.7%) patients
(seven patients with urinary tract infection, three with
endophthalmitis, two with pneumonia, one each with right
empyema, right psoas abscess and simultaneous endoph-
thalmitis and urinary tract infection) of the Klebsiella spp.
group, whereas all patients of the SM group had a localized
septic process without distant spread (10.7% vs. 0%,
p Z 0.06). The PLAs with distant spread tended to have
a longer duration of antibiotics than those PLAs without
(6.07 vs. 5.32 weeks, pZ 0.144; data not shown); this was
due to the longer mean duration of intravenous antibiotics
(3.85 vs. 2.86, p < 0.04; data not shown). The mortality
rates of both groups were comparable to each other. There
were 3(14.3%) deaths in the SM group and all were cancer-
related; two patients (one of them was newly diagnosed)
with cholangiocarcinoma and one patient with cancer of
the gallbladder. The Klebsiella spp. group had 12 (8.6%)
deaths; three cholangiocarcinoma, two cerebrovascular
accident, two respiratory failure, one each of cancer of
the pancreas, uncontrolled bleeding duodenal ulcer and
congestive heart failure.Discussion
PLA is the most common type of visceral abscess with
significant morbidity and mortality. The incidence is ex-
pected to increase with the risk factors including age,
diabetic mellitus and malignancy. Over the past few
decades, there have been observed significant changes in
etiology, bacteriology, diagnosis and management of
PLA.6e8 Recent reports reveal two important trends in the
pathology of PLA: Klebsiella spp. becomes one of the most
common organisms identified in Asian and Western pop-
ulations, and S. milleri is recognized as an emerging path-
ogen with a catch-up increase in incidence.
In this study, the mean age of the SM group was lower
than that of the Klebsiella spp. Group; by contrast, the
duration of symptoms prior to admission was longer in the
SM group. These were related to a higher proportion of
patients with Klebsiella infection caused by a biliary tract
disorder which is more commonly seen in elderly patients.Seeto and Rockey found that PLA presented most acutely (3
days) if it was due to bilary tract disorder.9 There was male
dominance in both groups, as in most previous reports.10e16
Diabetic mellitus was more associated with the Klebsiella
spp. group, but the figure was not as high as those of
previous Taiwan studies.11 The predilection for PLA in dia-
betic mellitus remains unclear, but the possible mechanism
is the impairment of phagocytosis of the pathogen.17 It is
a well-known fact that the underlying active malignancy is
also a risk factor and in this study, the association was
stronger with the SM group. The reason may be that SM,
a facultative anaerobe, grows more favorably in tumors
that are more acidic and hypoxic than in normal tissue.
The clinical manifestations of the patients of both
groups in the present study were similar to each other;
fever, chills and right upper quadrant pain were frequent
symptoms. However, the patients in the SM group were
more likely to experience right upper quadrant pain and
hepatomegaly, which may be explained by a higher inci-
dence of intrahepatic malignancies in this group. One-fifth
of both groups had an abnormality detected in the chest
radiograph, without any localizing signs in the abdomen,
which might cause a misdiagnosis of pneumonia. Laboratory
abnormalities were similar between the two groups, mainly
anemia, leukocytosis, high ESR and CRP, and deranged liver
function with elevated serum bilirubin and alkaline phos-
phatase. The changes in bilirubin and alkaline phosphatase
were more pronounced in the Klebsiella spp. group, which
may be due to its higher incidence of biliary tract disorder.
The predominance of right-lobe involvement was found in
both groups, which is consistent with prior reports. The
right lobe was most commonly involved due to its size and
propensity to receive most of the portal blood flow. The US
and CT appearance of both groups were similar to each
other. The former may range from hyperechoic to hypo-
echoic and this variation has a close relationship to the
pathologic stage of PLA. During the very early stage of
abscess formation, the hepatocytes undergo acute inflam-
mation and thus the abscess might appear solid, i.e.
hyperechoic. When the hepatocytes start necrosis, the
abscess becomes liquefied with increasing fluid content and
surrounding edema. This is also the stage at which most
patients with PLA present clinically; thus most PLA are
hypoechoic at US and are fluid-containing lesions with rim
enhancement in CT contrast study, which are consistent
to our findings. Gaseous cavitation was an infrequent
feature in this study, which is in agreement with previous
studies.10,12,15 In this study, a higher incidence of abscess
rupture in the Klebsiella spp. group might be accounted for
by its wall thickness and size.
As in recent reports, biliary disease was the most
common identifiable cause of PLA in our patients. Although
Chua et al found that 1/4 patients with SM group associated
PLA were caused by Crohn’s disease,18 our results did not
support this finding. This is because inflammatory bowel
disease in populations in Asian regions is still not as
common as that in Caucasians.19 Searching for an under-
lying cause is not routinely performed in our institution,
but in past few years, noninvasive imaging techniques, like
EUS and MRCP, have been increasingly used to define the
biliary anatomy instead of ERCP. A substantial number of
our cases were considered cryptogenic in both groups,
PLA caused by Streptococcus milleri and Klebsiella spp. 17although colonoscopy, ERCP and EUS were performed in
poor coverage.
In our study, both groups of PLA were well managed by
a combination of antibiotics and imaging-guided aspiration
with/without drainage. The empirical antibiotic should
cover both spectra of Gram positive cocci and Gram nega-
tive bacilli. Although antibiotic resistance was not common
in both groups, one should be alert to this possibility if the
clinical condition of the patient does not respond to the
treatment. In our study, all isolates of the SM group were
sensitive to an extended-spectrum of penicillin and this
might be due to the incidence of SM related PLA not as
high as that of Klebsiella spp. related. We expect SM
resistant strains will appear with an increasing incidence of
SM related PLA, similar to the situation in Klebsiella
spp. infection. Our findings showed that 10% of Klebsiella
isolates were resistant to penicillin, but all were sensitive
to quinolones and third generation cephalosporins. Never-
theless, one should be alert to the possibility of the
development of increasing antibiotic resistant strains in
the future. Patients in the Klebsiella spp. group received
appropriate antibiotic treatment with a small non-
statistical delay, as compared to those of the SM group,
owing to the presence of the resistant strain. We expect
this figure may increase with the incidence of antibiotic
resistance and subsequently this, together with the asso-
ciated adverse events, may have clinical implications. The
duration of antibiotic treatment in PLA has been based on
clinical experience of the clinician. Gao et al reported that
C-reactive protein can be used as a guide to determine the
duration of antibiotic treatment for PLA after complete
percutaneous drainage.20 The implication of a shorter
intravenous and longer oral antibiotic duration in the SM
group, as compared to the Klebsiella spp. group, is the
ability to switch over early to the oral counterpart once the
clinical condition, such as body temperature, white cell
count and CRP level, of the patient is in remission. This has
a good economic impact of shortening the length of stay in
hospital. The higher incidence of bacteremia, septic shock,
DIC, organ failure and acute coronary syndrome in the
Klebsiella spp. group indicates the need for suspicion of
PLA if blood culture yields Klebsiella spp.; abdominal
imaging and appropriate antibiotics should be initiated
without any delay.
The previous study reported that the metastatic infec-
tion rate of Klebsiella spp. group was higher than non-
Klebsiella group and that the endogenous endophthalmitis
was the predominant site of involvement.21 Our data
showed that this clinical feature did not confer any delay in
appropriate antibiotic and imaging-guided intervention.
Yang et al found that the K1 capsular serotype of Klebsiella
spp. associated with metastatic infection, owing to its
production of mucoviscous exopolysaccharide webs that
are resistant to complement-mediated serum killing and
thus allows bacilli to spread.22 Of these patients, 75% were
diabetic. The hypothesis of diabetic association is that
intimal vascular defect in diabetic patients may predispose
to hematogenous seeding of Klebsiella spp., and cause liver
abscesses and metastatic infections.23 In this study, the
incidence of metastatic infections in the Klebsiella spp.
group was markedly higher than in the SM group; these
infections were associated with a longer duration ofantibiotics, particularly the intravenous counterpart. This
implies that patients complicated with metastatic infec-
tion, may require a longer time to achieve clinical remis-
sion. In contrary to the previous Tawian studies, our results
showed that the most common site involved was the urinary
tract (8/15, 53.3%); the endogenous endophthalmitis was
the second most prevalent (4/15, 26.7%). Half of the
patients with metastatic infection were diabetic. All of the
urinary tract infections were asymptomatic and most of the
patients with endogenous endophthalmitis presented with
subacute vision impairment. The incidence of metastatic
infection might be under-estimated. Therefore, a high
index of clinical suspicion and the close monitoring of those
confirmed cases are warranted.
In this study, the mortality rate of SM and Klebsiella spp
associated liver abscesses were 14.3% and 8.6%, respec-
tively, which are comparable with other studies.24 No
general consensus has been achieved regarding prognostic
factors, and this may be due to differences in subject
populations.
In conclusion, the Streptococcus milleri associated
pyogenic liver abscess tends to have a distinct clinical
syndrome as compared with that of Klebsiella spp., in
regard to the different extent of risk factors, including
a small increase in risk of abdominal malignancy, clinical
manifestations and complications. However, both can be
effectively managed by the combination of antibiotic and
image-guided aspiration with/without drainage and their
mortality rates are comparable each other. Those with
metastatic infection might require a longer duration of
antibiotics, particular the intravenous counterpart.
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